[go: up one dir, main page]

WO2008136324A1 - ヘテロ環およびホスホノアミノ基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤 - Google Patents

ヘテロ環およびホスホノアミノ基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤 Download PDF

Info

Publication number
WO2008136324A1
WO2008136324A1 PCT/JP2008/057851 JP2008057851W WO2008136324A1 WO 2008136324 A1 WO2008136324 A1 WO 2008136324A1 JP 2008057851 W JP2008057851 W JP 2008057851W WO 2008136324 A1 WO2008136324 A1 WO 2008136324A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
atom
phosphonoamino
hydrogen atom
alkoxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057851
Other languages
English (en)
French (fr)
Inventor
Keigo Tanaka
Eiichi Yamamoto
Naoaki Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Priority to MX2009011532A priority Critical patent/MX2009011532A/es
Priority to BRPI0808833-0A priority patent/BRPI0808833A2/pt
Priority to JP2009512940A priority patent/JPWO2008136324A1/ja
Priority to AU2008246754A priority patent/AU2008246754B2/en
Priority to EP08740790A priority patent/EP2141171A4/en
Priority to NZ578930A priority patent/NZ578930A/en
Priority to CA002684503A priority patent/CA2684503A1/en
Publication of WO2008136324A1 publication Critical patent/WO2008136324A1/ja
Priority to IL201421A priority patent/IL201421A0/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　本発明は、優れた抗真菌作用を有し、物性、特に、水への溶解性、および安全性の面でも優れた抗真菌剤を提供する。本発明によれば、下式（I）で表される化合物またはその塩； 　[式中、 Ｒ１が、水素原子、ハロゲン原子、アミノ基、Ｒ１１－ＮＨ－（Ｒ１１が、Ｃ１－６アルキル基、ヒドロキシＣ１－６アルキル基、Ｃ１－６アルコキシＣ１－６アルキル基、またはＣ１－６アルコキシカルボニルＣ１－６アルキル基を意味する。）、Ｒ１２－（ＣＯ）－ＮＨ－（Ｒ１２が、Ｃ１－６アルキル基またはＣ１－６アルコキシＣ１－６アルキル基）、Ｃ１－６アルキル基、ヒドロキシＣ１-６アルキル基、シアノＣ１-６アルキル基、Ｃ１－６アルコキシ基、またはＣ１－６アルコキシＣ１－６アルキル基、またはホスホノアミノ基を意味し；Ｒ２が、水素原子、Ｃ１-６アルキル基、アミノ基、ジＣ１-６アルキルアミノ基、またはホスホノアミノ基を意味し；ＸおよびＹの一方が、窒素原子を、他方が、窒素原子または酸素原子を意味し；環Ａが、ハロゲン原子もしくはＣ１-６アルキル基を１個もしくは２個有していてもよい、５もしくは６員のへテロアリール環またはベンゼン環を意味し；Ｚが、単結合、メチレン基、エチレン基、酸素原子、硫黄原子、－ＣＨ２Ｏ－、－ＯＣＨ２－、－ＮＨ－、－ＣＨ２ＮＨ－、－ＮＨＣＨ２－、－ＣＨ２Ｓ－、または－ＳＣＨ２－を意味し；Ｒ３が、水素原子、ハロゲン原子、または、置換基を１個もしくは２個有していてもよい、Ｃ１－６アルキル基、Ｃ３－８シクロアルキル基、Ｃ６－１０アリール基、５もしくは６員へテロアリール基、または５もしくは６員の非芳香族系へテロ環式基を意味し；Ｒ４が、水素原子またはハロゲン原子を意味する。 　ただし、Ｒ１およびＲ２のいずれか一方はホスホノアミノ基を意味する。」を開示する。
PCT/JP2008/057851 2007-04-27 2008-04-23 ヘテロ環およびホスホノアミノ基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤 Ceased WO2008136324A1 (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MX2009011532A MX2009011532A (es) 2007-04-27 2008-04-23 Derivados de piridina sustituidos por un anillo heterociclico y grupo fosfonoamino, y agente anti-fungal que contiene los mismos.
BRPI0808833-0A BRPI0808833A2 (pt) 2007-04-27 2008-04-23 Derivados de piridina substituídos por anel heterocíclico e grupo fosfonoamino, e agente antifúngico contendo o mesmo
JP2009512940A JPWO2008136324A1 (ja) 2007-04-27 2008-04-23 ヘテロ環およびホスホノアミノ基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤
AU2008246754A AU2008246754B2 (en) 2007-04-27 2008-04-23 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
EP08740790A EP2141171A4 (en) 2007-04-27 2008-04-23 HETEROCYCLE-SUBSTITUTED PYRIDINE DERIVATIVE AND PHOSPHONOAMINO AND ANTIFUNGAL AGENT CONTAINING THE SAME
NZ578930A NZ578930A (en) 2007-04-27 2008-04-23 Pyridine derivatives substituted by heterocycle ring and phosphonoamino and antifungal agent containing the same
CA002684503A CA2684503A1 (en) 2007-04-27 2008-04-23 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
IL201421A IL201421A0 (en) 2007-04-27 2009-10-11 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91461507P 2007-04-27 2007-04-27
JP2007-118356 2007-04-27
JP2007118356 2007-04-27
US60/914,615 2007-04-27

Publications (1)

Publication Number Publication Date
WO2008136324A1 true WO2008136324A1 (ja) 2008-11-13

Family

ID=39943436

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057851 Ceased WO2008136324A1 (ja) 2007-04-27 2008-04-23 ヘテロ環およびホスホノアミノ基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤

Country Status (16)

Country Link
US (1) US8507530B2 (ja)
EP (1) EP2141171A4 (ja)
JP (1) JPWO2008136324A1 (ja)
KR (1) KR20100015909A (ja)
CN (1) CN101668767A (ja)
AU (1) AU2008246754B2 (ja)
BR (1) BRPI0808833A2 (ja)
CA (1) CA2684503A1 (ja)
IL (1) IL201421A0 (ja)
MX (1) MX2009011532A (ja)
NZ (1) NZ578930A (ja)
RU (1) RU2009143926A (ja)
SA (1) SA08290258B1 (ja)
TW (1) TW200841879A (ja)
WO (1) WO2008136324A1 (ja)
ZA (1) ZA200905435B (ja)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009084621A1 (ja) * 2007-12-27 2009-07-09 Eisai R & D Management Co., Ltd. ヘテロ環およびホスホノキシメチル基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤
WO2010032874A1 (ja) * 2008-09-19 2010-03-25 住友化学株式会社 農業用組成物
WO2011051198A2 (de) 2009-10-30 2011-05-05 Bayer Cropscience Ag Pyridin-derivate als pflanzenschutzmittel
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
US8507530B2 (en) 2007-04-27 2013-08-13 Eisai R&D Management Co., Ltd. Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
JP2014034523A (ja) * 2012-08-07 2014-02-24 Manac Inc モノまたはジハロゲノピリジルアミン類の製造方法
WO2017178549A1 (en) 2016-04-12 2017-10-19 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2020179859A1 (ja) 2019-03-06 2020-09-10 第一三共株式会社 ピロロピラゾール誘導体
JP2021512946A (ja) * 2018-02-05 2021-05-20 ユニヴェルスィテ・ドゥ・ストラスブール 疼痛を治療するための化合物および組成物
JP2023553057A (ja) * 2020-12-15 2023-12-20 メッドシャイン ディスカバリー インコーポレイテッド アミノピリジン系化合物及びその使用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033079A1 (ja) * 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
EP2065377B1 (en) 2006-09-21 2011-11-23 Eisai R&D Management Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
JP2012176900A (ja) * 2009-06-24 2012-09-13 Eisai R & D Management Co Ltd （（ホスホノオキシ）メチル）ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤
ITMI20110362A1 (it) * 2011-03-09 2012-09-10 F I S Fabbrica Italiana Sint P A Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
WO2014160739A2 (en) * 2013-03-27 2014-10-02 Cellmosaic Inc. Trifluoroborate mass spectrometric tags
EP3816155A1 (en) * 2013-08-23 2021-05-05 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
US11512079B2 (en) 2017-12-07 2022-11-29 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents
JP2021530445A (ja) 2018-06-25 2021-11-11 アンプリックス ファーマシューティカルズ，インク． 複素環およびアミノ基によって置換されたピリジン誘導体
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124154A2 (en) * 1983-04-22 1984-11-07 Shell Internationale Researchmaatschappij B.V. Aniline compositions, their preparation, compositions containing them, and method of combating fungus and/or combating or regulating plant growth
US5691336A (en) 1994-03-04 1997-11-25 Merck & Co., Inc. Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
WO2002004626A1 (en) 2000-07-07 2002-01-17 Eisai Co., Ltd. Fungal cell wall synthesis gene
WO2002085897A1 (en) 2001-04-05 2002-10-31 Alangudi Sankaranarayanan Heterocyclic compounds for aging-related and diabetic vascular complications
WO2003031435A1 (en) 2001-10-06 2003-04-17 Merck Patent Gmbh Pyrazole derivatives as glycine transporter inhibitors
WO2004089931A1 (de) 2003-04-05 2004-10-21 Merck Patent Gmbh Substituierte pyrazole
WO2005033079A1 (ja) 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤
JP2005526751A (ja) * 2002-03-08 2005-09-08 ビーエーエスエフ アクチェンゲゼルシャフト ｐｒｏｔｈｉｏｃｏｎａｚｏｌｅをベースにし、殺虫剤を含有する殺菌性混合物
JP2006519247A (ja) * 2003-03-01 2006-08-24 アストラゼネカ アクチボラグ 抗生物質として有用なヒドロキシメチル置換ジヒドロイソオキサゾール誘導体

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB919073A (en) 1960-09-15 1963-02-20 Farmaceutici Italia Benzylamine derivatives
JPS542325A (en) 1977-06-07 1979-01-09 Sankyo Co Ltd Agricultural and horticultural pesticide
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
JPS57179192A (en) 1981-04-27 1982-11-04 Takeda Chem Ind Ltd Ethylene glycol derivative
JPS5973575A (ja) 1982-10-05 1984-04-25 Shionogi & Co Ltd プロピニルアミノイソオキサゾ−ル誘導体
JPS5984824A (ja) 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE3316187A1 (de) 1983-05-04 1984-11-08 Cassella Ag, 6000 Frankfurt 2-(aminomethyl)-pyrrol-derivate, verfahren zu ihrer herstellung und ihre verwendung
EP0124067B1 (de) * 1983-05-04 1986-12-17 CASSELLA Aktiengesellschaft 2-(Aminoalkyl)-pyrrol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
WO1986003203A1 (fr) 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体
US5070082A (en) * 1986-10-23 1991-12-03 American Cyanamid Company Solubilized pro-drugs
US4851423A (en) 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
IL89028A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Quinoline,quinazoline and cinnoline derivatives
US5034393A (en) * 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
US5120704A (en) * 1989-11-08 1992-06-09 The United States Of America As Represented By The Secretary Of The Navy Method of making Tl-Sr-Ca-Cu-oxide superconductors comprising heating at elevated pressures in a sealed container
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
US5208247A (en) * 1991-08-01 1993-05-04 American Cyanamid Company Pyridinium compounds which are useful as antagonists of platelet activating factor
EP0533130A1 (de) 1991-09-19 1993-03-24 Hoechst Aktiengesellschaft 2-Hydroxymethylpyridine, die entsprechenden Pyridin-N-oxide und ihre Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung
AU2697092A (en) 1991-10-08 1993-05-03 Nippon Soda Co., Ltd. Pyrazole derivative and agrohorticultural bactericide containing same
US5710181A (en) * 1991-12-16 1998-01-20 Washington University Inhibition of nitric oxide formation in inflammatory bowel disease
SE9103776D0 (sv) 1991-12-19 1991-12-19 Astra Ab New compounds
US5235728A (en) * 1992-07-30 1993-08-17 H.M. Electronics, Inc. Fastening device for portable equipment and method of using same
KR100196356B1 (ko) 1993-09-28 1999-06-15 오스카 아끼히꼬 당뇨병 치료제
EP0738264A1 (en) 1994-01-07 1996-10-23 Dowelanco N-(4-pyrimidinyl)amide pesticides
DE4434637A1 (de) * 1994-09-28 1996-04-04 Hoechst Schering Agrevo Gmbh Substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
DE69618370T2 (de) * 1995-04-11 2002-09-26 Mitsui Chemicals, Inc. Substituierte Thiophenderivate und diese als aktiver Bestandteil enthaltenden Fungizide für Land- und Gartenbauwirtschaft
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
US6080767A (en) * 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
JP2000504336A (ja) 1996-02-02 2000-04-11 ゼネカ・リミテッド 薬学製剤として有用なヘテロ環式化合物
GB9605437D0 (en) 1996-03-15 1996-05-15 Iaf Biochem Int Cytomegalovirus inhibiting compounds
US5945431A (en) * 1996-03-15 1999-08-31 Biochem Therapeutics Incorporated Cytomegalovirus inhibiting compounds
ES2202641T3 (es) 1996-09-12 2004-04-01 Bioenhancement Systems Corporation Aparato para aplicaciones de presion controlada en humanos.
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
TR200001847T2 (tr) * 1997-04-04 2002-06-21 Pfizer Products Inc. Nikotinamid Türevleri
US6200975B1 (en) * 1997-05-08 2001-03-13 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands
DE19727117A1 (de) 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19732033A1 (de) * 1997-07-25 1999-01-28 Bayer Ag Triazolinthion-phosphorsäure-Derivate
US6407116B1 (en) * 1997-09-16 2002-06-18 Takeda Chemical Industries, Inc. Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
CN1283995A (zh) * 1997-12-11 2001-02-14 生化制药有限公司 抗病毒化合物
EP1051181B1 (en) 1997-12-31 2004-03-17 The University Of Kansas Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea
JP2000178243A (ja) 1998-12-14 2000-06-27 Teijin Ltd ビフェニルアミジン誘導体
US6235728B1 (en) * 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
US6340690B1 (en) * 1999-02-22 2002-01-22 Bio-Chem Pharma Inc. Antiviral methods using [1,8]naphthyridine derivatives
US6319944B1 (en) * 1999-05-10 2001-11-20 Merck & Co., Inc. Aryl amidines, compositions containing such compounds and methods of use
GB9919588D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
TWI262185B (en) 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
JP4831907B2 (ja) 1999-10-08 2011-12-07 アフィニアム・ファーマシューティカルズ・インコーポレイテッド ＦａｂＩ阻害剤
WO2001036003A2 (en) 1999-11-15 2001-05-25 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US6414013B1 (en) * 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
CN100467597C (zh) * 2000-07-07 2009-03-11 卫材R&D管理有限公司 真菌细胞壁合成基因
DE10039477A1 (de) 2000-08-08 2002-02-21 Aventis Cropscience Gmbh Heterocyclylalkylazol-Derivate und ihre Verwendung als Schädlingsbekämpfungsmittel
JP2004508421A (ja) 2000-09-15 2004-03-18 アノーメッド　インコーポレイティド ケモカインレセプター結合性ヘテロ環式化合物
JP2004518629A (ja) * 2000-09-18 2004-06-24 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌・殺カビ剤として使用するためのピリジニルアミド類およびイミド類
EP1217000A1 (en) 2000-12-23 2002-06-26 Aventis Pharma Deutschland GmbH Inhibitors of factor Xa and factor VIIa
ATE293109T1 (de) 2001-01-31 2005-04-15 Pfizer Prod Inc Nikotinsäureamid-derivate und ihre mimetika als inhibitoren von pde4-isozyms
JP2002275159A (ja) 2001-03-16 2002-09-25 Japan Tobacco Inc Ｈｃｐ阻害剤及びｈｃｐ阻害活性を有する化合物
GB0109122D0 (en) * 2001-04-11 2001-05-30 Smithkline Beecham Spa Novel compounds
EP1275653A1 (en) 2001-07-10 2003-01-15 Bayer CropScience S.A. Oxazolopyridines and their use as fungicides
EP1275301A1 (en) 2001-07-10 2003-01-15 Bayer CropScience S.A. Trisubstituted heterocyclic compounds and their use as fungicides
JP2005509594A (ja) 2001-07-13 2005-04-14 バーチャル ドラッグ ディヴェロップメント、インコーポレイティッド Ｎａｄシンテターゼ阻害剤およびその使用
US20040198773A1 (en) * 2001-09-26 2004-10-07 Barry Hart Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
KR100437972B1 (ko) * 2001-10-27 2004-07-02 한국과학기술연구원 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물
EP2336133A1 (en) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
JP4216193B2 (ja) 2001-11-27 2009-01-28 エフ．ホフマン−ラ ロシュ アーゲー ベンゾチアゾール誘導体
WO2003045920A1 (en) 2001-11-27 2003-06-05 Merck & Co., Inc. 4-aminoquinoline compounds
US20030191158A1 (en) 2002-02-11 2003-10-09 Magee Thomas V. Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
DK1474395T3 (da) 2002-02-12 2008-02-11 Smithkline Beecham Corp Nicotinamidderivater, der er nyttige som p38-inhibitorer
EP1485085A4 (en) 2002-03-20 2007-03-14 Bristol Myers Squibb Co PHOSPHATE PRODRUGS OF FLUORO XINDOLS
ES2307925T3 (es) * 2002-04-26 2008-12-01 Eli Lilly And Company Antagonistas de los receptores de la taquiquinina.
EP1369420A1 (en) 2002-06-06 2003-12-10 Aventis Pharma Deutschland GmbH Inhibitors of the GPib - vWF interaction
CA2495120A1 (en) 2002-08-09 2004-02-19 Astrazeneca Ab Oxadiazoles as modulators of metabotropic glutamate receptor-5
PA8578101A1 (es) * 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
GB0222495D0 (en) 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
AU2003271117A1 (en) 2002-10-09 2004-05-04 Ssp Co., Ltd. Novel pyrazole compounds having antifungal activity
KR100933759B1 (ko) 2002-11-22 2009-12-23 에자이 알앤드디 매니지먼트 가부시키가이샤 말라리아 기생충에서 ｇｐｉ의 생합성을 억제하는 화합물을스크리닝하는 방법
WO2004052280A2 (en) 2002-12-10 2004-06-24 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
US8030336B2 (en) * 2002-12-13 2011-10-04 Ym Biosciences Australia Pty Ltd Nicotinamide-based kinase inhibitors
JP4156460B2 (ja) 2003-07-09 2008-09-24 Ｔｄｋ株式会社 ワークのピックアップ方法及びその装置、実装機
AU2004261589B2 (en) * 2003-07-25 2008-05-22 Novartis Ag p-38 kinase inhibitors
JO2525B1 (en) 2004-04-08 2010-03-17 شركة جانسين فارماسوتيكا ان. في Derived 4-alkyl-and-4-canoelperidine derivatives and their use as anti-neroquin
JP4885722B2 (ja) 2004-06-30 2012-02-29 富山化学工業株式会社 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤
US20090227799A1 (en) * 2004-08-09 2009-09-10 Kazutaka Nakamoto Novel Antimalarial Agent Containing Heterocyclic Compound
EP1782811A4 (en) 2004-08-09 2010-09-01 Eisai R&D Man Co Ltd INNOVATIVE ANTIPALUDITIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
WO2006106711A1 (ja) 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
WO2007052615A1 (ja) * 2005-10-31 2007-05-10 Eisai R & D Management Co., Ltd. ヘテロ環置換ピリジン誘導体およびそれらを含有する抗真菌剤
WO2007056215A2 (en) 2005-11-02 2007-05-18 Cytovia, Inc. N-aryl-thienopyrimidin-4-amines and the use thereof
EP2001298A2 (de) * 2006-03-27 2008-12-17 Basf Se Substituierte 5-hetaryl-4-aminopyrimidine
EP2065377B1 (en) * 2006-09-21 2011-11-23 Eisai R&D Management Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
CN101522195B (zh) 2006-10-06 2012-01-18 富山化学工业株式会社 含有苯基脒衍生物的药物组合物和该药物组合物与抗真菌剂的联合使用方法
CA2671737A1 (en) 2006-12-05 2008-06-12 Neurogesx, Inc. Prodrugs and methods of making and using the same
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
KR20100015897A (ko) * 2007-04-27 2010-02-12 에자이 알앤드디 매니지먼트 가부시키가이샤 헤테로환 치환 피리딘 유도체의 염 또는 그의 결정
WO2009081970A1 (ja) 2007-12-26 2009-07-02 Eisai R & D Management Co., Ltd. ヘテロ環置換ピリジン誘導体の製造方法
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
WO2009130462A1 (en) 2008-04-23 2009-10-29 Leafgreen Limited Manual pump type fluid dispenser
GB0809773D0 (en) 2008-05-29 2008-07-09 F2G Ltd Antifungal combination therapy
US8188119B2 (en) * 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
JP2012176900A (ja) * 2009-06-24 2012-09-13 Eisai R & D Management Co Ltd （（ホスホノオキシ）メチル）ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124154A2 (en) * 1983-04-22 1984-11-07 Shell Internationale Researchmaatschappij B.V. Aniline compositions, their preparation, compositions containing them, and method of combating fungus and/or combating or regulating plant growth
US5691336A (en) 1994-03-04 1997-11-25 Merck & Co., Inc. Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
WO2002004626A1 (en) 2000-07-07 2002-01-17 Eisai Co., Ltd. Fungal cell wall synthesis gene
WO2002085897A1 (en) 2001-04-05 2002-10-31 Alangudi Sankaranarayanan Heterocyclic compounds for aging-related and diabetic vascular complications
WO2003031435A1 (en) 2001-10-06 2003-04-17 Merck Patent Gmbh Pyrazole derivatives as glycine transporter inhibitors
JP2005526751A (ja) * 2002-03-08 2005-09-08 ビーエーエスエフ アクチェンゲゼルシャフト ｐｒｏｔｈｉｏｃｏｎａｚｏｌｅをベースにし、殺虫剤を含有する殺菌性混合物
JP2006519247A (ja) * 2003-03-01 2006-08-24 アストラゼネカ アクチボラグ 抗生物質として有用なヒドロキシメチル置換ジヒドロイソオキサゾール誘導体
WO2004089931A1 (de) 2003-04-05 2004-10-21 Merck Patent Gmbh Substituierte pyrazole
WO2005033079A1 (ja) 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Jikkenkagakukoza", vol. 18, article "This step can be carried out according to the general methods", pages: 20 - 23
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 11, 2003, pages 2427 - 2437
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 12, no. 6, pages 531 - 536
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 41, no. 6, pages 931 - 939
JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, no. 5, pages 702 - 705
JOURNAL OF ORGANIC CHEMISTRY, vol. 49, no. 26, pages 5237 - 5243
TETRAHEDRON LETTERS, vol. 24, no. 31, pages 3165 - 3168
TETRAHEDRON LETTERS, vol. 40, no. 49, pages 8575 - 8578

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507530B2 (en) 2007-04-27 2013-08-13 Eisai R&D Management Co., Ltd. Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
WO2009084621A1 (ja) * 2007-12-27 2009-07-09 Eisai R & D Management Co., Ltd. ヘテロ環およびホスホノキシメチル基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
WO2010032874A1 (ja) * 2008-09-19 2010-03-25 住友化学株式会社 農業用組成物
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
WO2011051198A2 (de) 2009-10-30 2011-05-05 Bayer Cropscience Ag Pyridin-derivate als pflanzenschutzmittel
JP2014034523A (ja) * 2012-08-07 2014-02-24 Manac Inc モノまたはジハロゲノピリジルアミン類の製造方法
WO2017178549A1 (en) 2016-04-12 2017-10-19 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
JP2021512946A (ja) * 2018-02-05 2021-05-20 ユニヴェルスィテ・ドゥ・ストラスブール 疼痛を治療するための化合物および組成物
JP7506379B2 (ja) 2018-02-05 2024-06-26 ユニヴェルスィテ・ドゥ・ストラスブール 疼痛を治療するための化合物および組成物
WO2020179859A1 (ja) 2019-03-06 2020-09-10 第一三共株式会社 ピロロピラゾール誘導体
JP2023553057A (ja) * 2020-12-15 2023-12-20 メッドシャイン ディスカバリー インコーポレイテッド アミノピリジン系化合物及びその使用
JP7574450B2 (ja) 2020-12-15 2024-10-28 シーセン ファーマシューティカル カンパニー リミテッド アミノピリジン系化合物及びその使用

Also Published As

Publication number Publication date
BRPI0808833A2 (pt) 2014-08-26
TW200841879A (en) 2008-11-01
MX2009011532A (es) 2009-11-10
US8507530B2 (en) 2013-08-13
US20090082403A1 (en) 2009-03-26
CN101668767A (zh) 2010-03-10
ZA200905435B (en) 2010-09-29
EP2141171A4 (en) 2012-05-02
RU2009143926A (ru) 2011-06-10
JPWO2008136324A1 (ja) 2010-07-29
KR20100015909A (ko) 2010-02-12
AU2008246754A1 (en) 2008-11-13
IL201421A0 (en) 2010-05-31
AU2008246754B2 (en) 2012-07-12
EP2141171A1 (en) 2010-01-06
CA2684503A1 (en) 2008-11-13
SA08290258B1 (ar) 2011-10-08
NZ578930A (en) 2011-05-27

Similar Documents

Publication Publication Date Title
WO2008136324A1 (ja) ヘテロ環およびホスホノアミノ基が置換したピリジン誘導体ならびにそれらを含有する抗真菌剤
BRPI0817973A2 (pt) derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêutica
UA99637C2 (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащее их противогрибковое средство
WO2008078686A1 (ja) オキシムエステル化合物及び該化合物を含有する光重合開始剤
CY1121051T1 (el) Περιεχουσα αζωτο ετεροκυκλικη ενωση και γεωργικο/κηπουρικο σποριοκτονο
WO2005037783A3 (fr) Composes tricycliques comme inhibiteurs de transport de glycine
WO2009028543A1 (ja) 置換ピラゾール誘導体
MX2009013728A (es) Derivados de bicicloanilina.
WO2009054332A1 (ja) ピリドン置換ジヒドロピラゾロピリミジノン誘導体
EP1719763A4 (en) NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (2)
EP1724262A4 (en) 1- (2H) -ISOCHINOLONDERIVAT
TW200605883A (en) Condensed heterocycle derivative having HCV inhibitory activity
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
WO2008126890A1 (ja) ヒドラジド化合物およびそれを含有する有害節足動物防除剤
MY145746A (en) Heterocyclic substituted pyridine derivatives and antifungal agent containing same
WO2008155668A3 (en) Heteroarylamide pyrimidone compounds
WO2008155670A3 (en) Arylamide pyrimidone compounds
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
BR0308759A (pt) Derivados de fenil amidas siliconadas utilizáveis como microbiocida
EP1741714A4 (en) HETEROCYLIC COMPOUND AND ANTI-MALIGNANT TUMOR AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT
WO2009054742A3 (en) Novel precursors
WO2007144769A3 (en) Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
TW200745104A (en) Multikinase inhibitor
TW200504135A (en) Colored polymeric resin composition, article made therefrom, and method for making the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880013858.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740790

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008246754

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2009512940

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12009501476

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 5064/DELNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 578930

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2008246754

Country of ref document: AU

Date of ref document: 20080423

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008740790

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 201421

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2684503

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/011532

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2009101584

Country of ref document: EG

ENP Entry into the national phase

Ref document number: 20097022334

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009143926

Country of ref document: RU

ENP Entry into the national phase

Ref document number: PI0808833

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090915